Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

NCT04518774 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Ex-vivo expanded allogeneic γδT cells

Sponsor

Beijing 302 Hospital

Collaborators

[object Object]
[object Object]